BIRC5 and breast carcinoma: In this study, we evaluated the impact of some specific molecular alterations (activation of ERK1-2 proteins, amplification of CyclinD1 and h-prune genes, silencing of TP53 gene, overexpression of survivin protein) as predictive and prognostic factors among patients with T4 breast carcinoma.